Tony Arulanandam

Company: Synaptimmune Therapeutics

Job title: Chief Executive Officer and Founder

Seminars:

Panel Discussion: Uniting Industry & Academia to Accelerate Cell Therapy Development for Autoimmune Disease

Moderator – Greg Deener, Chief Executive Officer, iCell Gene Therapeutics 11:30 am

• How can we foster increased partnerships between industry and academic/clinical institutions to strengthen our understanding of current autoimmune indications? • How do we build on the established experiences where academic clinical trials provided early POC for cell therapy in AID to attract investment and clinical development and commercialization of cell therapies in the autoimmune…Read more

day: Day One Track B, AM

Next Generation of Dual Antigen IDR-CAR-T cells for Autoimmune Diseases 2:00 pm

• Discussing increased potency, sensitivity and complete immune reset of dual antigen targeting IDR-CAR-T cells • Proof of concept data for SLE and other autoantibodymediated autoimmune indications targeting B and T-cells • Development of best-in-class next generation of immune cell depleting CAR-T cells and tissue or organ system modulating CAR-Tregs NEW DATARead more

day: Day One Track A, PM